Stability in the US and in International Growth

While the Spine market remains sluggish in the US, international sales are picking up the slack. The Q2 WW Spine Hardware market improved nearly 2% during the quarter despite...

Among the many topics covered in the Q218 Spine Market Recap are:

Computer Assisted Surgery - Spine is the latest module added to SmartTRAK Business Intelligence and Will Be Launched at the North American Spine Surgery (NASS) Meeting

BioMedGPS announces expanded coverage of SmartTRAK Business Intelligence in the realm of Robotic and Computer Assisted Surgery with the launch of its first module, US Computer Assisted Surgery (CAS) – Spine at the upcoming NASS conference later this month. A second SmartTRAK module, US Computer Assisted Surgery (CAS) – Ortho, will be introduced in November.

Extremities market experiences slight gains due to expanded product portfolios 

The US Extremities Market experienced a slight gain in Q218 according to SmartTRAK Financial Dashboard, slightly lower than the rate anticipated in the US Extremities Market Overview. We anticipate the Extremities segment rebounding to achieve...

Among the many topics covered in the Q218 Extremities Market Recap are:

• Competition in Shoulders Heating Up
• Expanded Portfolios and Awareness Driving Continued Ankle Growth
• Extremities Fixation: Company Focus and New Product Intros Incite Growth
• Regulatory Highlights

US market experiences slight softening as the top four trauma players all post sequential declines in Q218

The WW Trauma Market was up in Q218 – the third consecutive quarter of growth in the +4% range. Internationally, positive sales growth in Europe offset a sequential slowdown in Rest of World (ROW). In Europe, revenues were steady, while ROW sales dipped sequentially as the top players reported softer growth due to tough comps as a result of 2017 tender orders...

Among the many topics covered Q218 Trauma Market Recap are:

Volume Up, Pricing Down, Overall Market Lower

Now that Q218 results are in, the US Joint Fluid market continued to experience downward pressure posting negative growth of -6.5% for the quarter and -4.0% YTD, according to SmartTRAK Financial Dashboard results ...

Cerapedics’ CEO Glen Kashuba and President and COO Jeff Marx, Ph.D. discuss the future of the bone graft substitutes and the uniqueness of i‑FACTOR Peptide Enhanced Bone Graft, a small peptide technology in an interview with Kim French, Sr. Analyst, SmartTRAK Orthbio.

A transcript of SmartTRAK's interview with Glen Kashuba and Jeff Marx is below, or click on the following video to listen to the interview.

SmartTRAK is excited to be attending AOFAS 2018 - American Orthopaedic Foot & Ankle Society - on July 11-14, 2018 in Boston, Massachusetts.

Representing SmartTRAK will be Natasha Weeks, Sr. Analyst, Trauma & Extremities Fixation, Christopher McCarthy, VP Corporate Accounts, Orthopedics and Neuro and Michelle Calderon, Account Manager, Orthopedics. Please contact us if you would like a meeting!

SmartTRAK looks behind the curtain at the interplay of factors truly driving growth in the US Soft Tissue Fixation Market.

With the US Soft Tissue Fixation Market worth an estimated $1.5B, SmartTRAK looked behind industry’s curtain at the interplay of factors driving the 5.3% CAGR in the sports medicine market to see what’s truly driving growth in the market. Does clinical research drive product development? Or does industry develop and market products that drive usage followed by studies that measure their efficacy? From aggressive marketing campaigns to company compensation plans to sole source agreements, there is an increasing number of factors driving the soft tissue fixation market outside of research and clinical findings.

SmartTRAK's  Trauma & Extremities Fixations Sr. Analyst Natasha Weeks identified several key product trends at the Orthopaedic Trauma Association’s (OTA) 33rd Annual Meeting in Vancouver, BC Oct. 11-14, 2017, as manufacturers looked to differentiate themselves and gain share in the US Trauma market, projected to reach over $2.2B by 2021. 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Soft Tissue Fixation Market Recap.

Seasonality slowed Soft Tissue Fixation market growth, but the addition of biologics to RC repair implants makes the future promising. The US soft tissue fixation market continued to grow at 3.3% YoY...

Among the many topics covered in the full Q118 Soft Tissue Fixation Market Recap are: